Domiodol
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162708This classification denotes a mucolytic agent with the molecular formula C5H9IO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) C1PXF8V06N, chemically known as 1,3-dioxolane-4-methanol, 2-(iodomethyl)-, (e,z)- but more generally known as domiodol, which bears US NIH Compound Identifier 43814. European Medicines Agency schedules Domiodol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06355MIG. The term DOMIODOL is an International Non-Proprietary Name. World Health Organization schedules domiodol in its Anatomical Therapeutic Chemical (ATC) Classification. DOMIODOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule domiodol under HS 29329970 and SITC 51569. As of Q4 2014, DOMIODOL remains US FDA's Preferred Term for this commodity. Domiodol bears US NLM identifiers UMLS ID C0048365 and NCI Concept Code C65461. SMILES: ICC1OC(CO1)CO.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.